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Abstract
Background: Surgical site infection (SSI) remains a significant problem in the postoperative period that can
negatively affect clinical outcomes. Microbiology findings are typically similar to other nosocomial infections,
with differences dependent on microbiology selection due to antibiotic pressure or the resident flora. However,
this is poorly understood in the critical care setting. We therefore aimed to assess the incidence, epidemiology
and microbiology of SSI and its association with outcomes in patients with severe peritonitis in the intensive
care unit (ICU).
Methods: We prospectively studied 305 consecutive patients admitted to our surgical ICU from 2010 to 2014
with a diagnosis of secondary or tertiary peritonitis. We collected the following data: SSI diagnosis, demographics,
Acute Physiology and Chronic Health Evaluation (APACHE) II score, Simplified Acute Physiology Score (SAPS) II
score, type of surgery, microbiology, antibiotic treatment and outcomes. Microbiological sampling was done by
means of swabs.
Results: We identified 269 episodes of SSI in 162 patients (53.1 %) aged 64.4 ± 14.3 years, of which 200 episodes
occurred in men (64.6 %). The mean APACHE II and SAPS II scores were 19.7 ± 7.8 and 36.5 ± 16.1 respectively. The
mean ICU and hospital stays were 19.8 ± 24.8 and 21.7 ± 30 days respectively. Pseudomonas spp. (n = 52, 19.3 %),
Escherichia coli (n = 55, 20.4 %) and Candida spp. (n = 46, 17.1 %) were the most frequently isolated microorganisms,
but gram-positive cocci (n = 80, 29.7 %) were also frequent. Microorganisms isolated from SSIs were associated with a
higher incidence of antibiotic resistance (64.9 %) in ICU patients, but not with higher in-hospital mortality. However,
patients who suffered from SSI had longer ICU admissions (odds ratio = 1.024, 95 % confidence interval 1.010–1.039,
P = 0.001).
Conclusions: The incidence of SSI in secondary or tertiary peritonitis requiring ICU admission is very high. Physicians
may consider antibiotic-resistant pathogens, gram-positive cocci and fungi when choosing empiric antibiotic
treatment for SSI, although more studies are needed to confirm our results due to the inherent limitations of the
microbiological sampling with swabs performed in our research. The presence of SSI may be associated with
prolonged ICU stays, but without any influence on overall mortality.
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Background
The skin is the main barrier against bacterial infection of
internal tissues, and surgical wounds create a physical
disruption to that barrier. The movement of bacteria
across the skin barrier can lead to surgical site infections
(SSI), one of the most frequent infectious complications
of surgical procedures, with the potential risk for adverse
outcomes [1]. SSI involves different inflammatory re-
sponses that range from low to high clinical significance
[2], with that following abdominal surgery being a typ-
ical example associated with increased morbidity and
mortality [2–5]. Worse still, SSI can spread to surround-
ing areas and vital deep structures, often requiring
debridement or drainage [3, 4]. Consequently, the treat-
ment of SSI leads to increased costs, especially when we
consider the high number of surgical procedures and
their complexity in a typical referral hospital [2–5].
Peritonitis, which is defined as inflammation of the
serous membrane that covers the abdominal cavity and
their organs, is classified into primary (spontaneous),
secondary (process-related pathology in the visceral
organs) and tertiary (persistent or recurrent after initial
adequate surgical treatment). Secondary and tertiary
peritonitis are associated with higher morbidity with
mortality rates of 17–63 % [6, 7]. Tertiary peritonitis
usually occurs in ICU settings at least 48–72 h following
adequate treatment of secondary peritonitis, and has a
mortality rate of 30–60 % [8].
Centers for Disease Control and Prevention (CDC) es-
timates that the risk of SSI associated with abdominal
surgery ranges from approximately 2 to 8 %, depending
on the type of surgery [2, 3, 9, 10]. SSI is classified into
several categories: clean (2 %), clean-contaminated (3 %),
contaminated (6 %) and dirty (7 %) [2, 11]. Stratification
before surgery could help identify at-risk patients suit-
able for surveillance [3].
Despite the marked influence of SSI associated with
severe peritonitis on public health and clinical practice,
it has been poorly addressed in the literature, even in
the ICU setting. This study therefore aimed to describe
the incidence, epidemiology, microbiology and outcomes
of SSI in patients admitted with secondary or tertiary
peritonitis to the ICU of a tertiary referral hospital.
Materials and methods
This prospective, observational study was carried out
at from January 2010 to December 2014. At the time
this study was performed, the Hospital Universitari de
Bellvitge (HUB) was a tertiary hospital with 850 general
care beds and 44 ICU beds. We included all consecutive
patients from any type of abdominal surgery who re-
quired ICU admission beyond 72 h for secondary or
tertiary peritonitis. All patients received standard pre-
operative hygiene care and antibiotic prophylaxis at
anaesthetic induction consistent with our institutional
protocols for elective and emergency surgery [4].
SSI was defined using the CDC definition [11] and
diagnosis was by the responsible physicians, based on
clinical criteria. Any purulent drainage from a surgical
incision with signs of inflammation of the surrounding
tissue was considered an SSI, whether microorganisms
were isolated in cultures or not. The infection had to
present at the surgical site within 30 days of surgery
[2–4]. The study was approved by the Institutional
Ethics Committee of our hospital (Comité d’ Ètica i
Assajos Clínics de HUB (CEIC); Ethics and Clinical Assays
Committee of HUB), and informed consent was waived
due to the observational design.
In all patients, the decisions regarding ICU admission
and treatment were made by the treating physician. Data
were recorded from the medical registry of each patient
in real time, using a standardised questionnaire, and col-
lected in a database. The following information was
recorded on admission: demographic data, medical his-
tory and comorbidities, surgical indication and type of
surgery (elective or emergency), surgical technique, in-
traoperative variables (number of drains inserted), mi-
crobiologic findings, arterial lactate on admission and
treatment characteristics. During their ICU stay, we also
recorded the following: need for vasopressor drugs,
mechanical ventilation and renal replacement therapy
(RRT) and; any new microbiological findings, including
the appropriateness, changes and resistance to antibiotic
treatment. Illness severity was quantified with the Acute
Physiology and Chronic Health Evaluation (APACHE)
and Simplified Acute Physiology Score (SAPS) scoring
systems during the first 24 h of ICU admission for all
patients. After ICU discharge, follow-up was planned to
collected data on in-hospital mortality and patients were
followed until discharge from ICU or until resolution.
The surgical teams collaborated with ICU physicians
to control the SSI, using simple washouts or serial de-
bridements when appropriate. We obtained tissue sam-
ples and exudate samples, and direct needle aspiration
was used when needed, in collaboration with the surgical
team. The microbiological samples were obtained under
conditions as sterile as possible in order to avoid colo-
nizers of the superficial wound. The deepness of tissue
sample was evaluated based on SSI characteristics. If ne-
cessary, drainage was performed, and any necrotic tissue
was debrided and foreign material removed. Intensive
irrigation with saline solution was employed when
necessary to facilitate mechanical debridement [2]. We
provided rational antibiotic therapy based on local
guidelines and after consultation with an infectious
disease physician.
For diagnosis purposes, microbiological samples were
sent to the laboratory as swabs in culture media for
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semiquantitative aerobic and anaerobic cultures. To
isolate anaerobes, specimens were inoculated into
Columbia blood agar plates enriched with hemin and
menadione, incubated in an anaerobic chamber at 37 °C,
and specimens were Gram stained at 48 and 96 h for
direct examination.
Statistical analysis was conducted using PASW Statistics
13.0 (SPSS Inc., Chicago, Illinois, USA). Continuous
data are expressed as mean ± standard deviation and
categorical data are expressed as percentages. Compari-
sons between groups with non-normal distributions
were by two-sample t-tests or Mann–Whitney U tests
after applying the one-sample Kolmogorov–Smirnov
test. The χ2-test was used to evaluate categorical vari-
ables. Multivariable analysis was done to assess the in-
fluence of SSI and other SSI-related factors, such as the
microbiology results, on mortality and outcomes. Odds
ratios (ORs) and 95 % confidence intervals (CIs) are
quoted as appropriate. A P-value of 0.05 was consid-
ered statistically significant in all cases.
Results
Of the 305 patients hospitalised for secondary or tertiary
peritonitis in our ICU, we identified 269 episodes of SSI
in 162 patients. The SSI rate of 53.1 % was higher in
ICU compared with the rest of hospitalized patients
who underwent major abdominal surgery (n = 193/935;
20.6 %) during the study period (P < 0.001). Patient char-
acteristics, inflammatory response, type of surgery and
outcomes are shown in Table 1. The mean duration of
hospitalisation prior to surgery was 8.9 ± 2.5 days. Ur-
gent abdominal surgery comprised 28 %–35 % of all ab-
dominal surgeries performed at our hospital, showing a
difference in the type of surgery in comparison with ICU
patients (P = 0.01). The types of surgery (based on the
anatomical location) of the different identified SSI epi-
sodes are shown in Fig. 1. All patients were monitored
with a central venous catheter, arterial catheter and urin-
ary catheter, and all patients were on vasoactive drugs or
inotropic support.
In the studied population, we identified 1181 positive
culture isolates: 269 (22.7 %) were from SSIs, 486
(41.2 %) were from intra-abdominal abscesses, 251
(21.2 %) were from positive blood cultures (blood cul-
tures) and 175 (14.9 %) were from other cultures. The
microbiology results for isolates from SSI are shown
in Table 2, with a preponderance of Escherichia coli
(n = 55, 20.4 %) and Pseudomonas aeruginosa (n = 52,
19.3 %), while gram-positive cocci and Candida spp.
were also frequent at rates of 29.7 % (n = 80) and
17.1 % (n = 46) respectively. Antibiotic resistance to two
or more antibiotics occurred in 64.9 % (n = 174), with
rates of Extended spectrum beta-lactamase-producing
Enterobacteriaceae (n = 30) and Pseudomonas aeruginosa
carbapenem-resistant (n = 32) of 11.1 % and 11.9 %
respectively, but with low rates of typical multi-resistant
microorganisms such as Acinetobacter baumanii (2.9 %,
n = 8) and methicillin resistant Staphylococcus aureus
(MRSA) (2.2 %, n = 6). The microorganisms isolated from
intra-abdominal abscesses were the same of those
isolated in SSI samples in the 20.9 % of the patients
(n = 34) with similar rates of of multi-resistant bacteria.
No relationship was established between the intra-
abdominal abscesses and the occurrence of SSI based of
clinical and surgical evaluation. Based on the culture
antibiograms, 99.5 % of patients received appropriate
antibiotic treatment. The most commonly used antibi-
otics are shown in Table 2, with the use of multiple, sim-
ultaneous or sequential antibiotics being used in 72.5 %
of the cases (n = 195). A mean of 2.6 antibiotics was used
per SSI, with treatment lasting 14 ± 8 days.
Total mortality was 37.9 % (n = 116), from which
27.9 % (n = 85) correspond to ICU deaths. Although SSI
was not associated with higher mortality in our population
when confounders, such as variables that reflected disease
severity, were included in the multivariate analysis, it was
associated with a longer ICU stay (OR = 1.024, 95 % CI:
1.010–1.039; P = 0.001). Indeed, mortality was lower
in the group with SSI (OR = 0.547, 95 % CI 0.323–
0.924; P = 0.024). The need for RRT (OR = 3.358,
95 % CI: 1.619–6.966; P = 0.001) and prolonged ICU stay
(OR = 1.071, 95 % CI: 1.046–1.097; P < 0.001) were associ-
ated with higher in-hospital mortality.
Discussion
This study provides data on the incidence and micro-
biology of SSIs for a large cohort of critically ill patients
admitted with secondary or tertiary peritonitis to a sur-
gical ICU. It confirms that there was a high incidence of
SSI in those patients. The main findings of our study
were that SSI was associated with a prolonged ICU stay,
but that it had little impact on the overall in-hospital
mortality in our population.
The development of postoperative SSI is known to
have been multifactorial, arising from a complex rela-
tionship between host and environmental factors [1, 2].
Host risk factors for SSI include morbid obesity, disease
severity, advanced age, low blood-protein levels and mal-
nutrition, diabetes, malignancy and sepsis, while other
risk factors that include susceptibility include immuno-
suppression, smoking and having a distant infection site
[10]. Pre-existing morbidity, the time of surgery and the
type of SSI may also play key roles in the development
of SSIs [10]. Thus, an increasingly elderly population
with a greater number of comorbidities significantly in-
creases the risk of developing an SSI [9, 12]. Critically ill
patients represent an increasing proportion of the in-
patient population that will undoubtedly lead to greater
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diagnostic and management challenges, especially given
that most SSIs in the ICUs are nosocomial [9]. SSIs are
most common in high-risk patients, with an incidence of
about 11.7 % [12, 13].
Antibiotic prophylaxis reduces postoperative morbidity
and length of hospital stay, which positively affects SSI-
related costs [4]. Wounds with a risk of infection below
2 % do not generally require antibiotic prophylaxis, but
notable exceptions include the placement of a prosthesis,
cardiovascular surgery and neuro-surgery [14]. Up to
15 % of all elective surgical patients may develop an
SSI, with rates as high as 30 % being common in
contaminated or dirty surgical procedures [5]. In our
study, the majority of procedures were considered dirty
or contaminated, and many of the critically ill patients
had markedly decreased serum protein concentrations.
Together, these may ultimately explain our higher SSI
rate. Our higher rates may also reflect the inherent risks
of tertiary care institutions and the severity of our co-
hort. Therefore, our results may not be applicable to
secondary and non-referral hospitals.
An SSI can increase hospital stay by about six days
and can add 10–20 % to hospital costs, even leading to
death; therefore, prevention and control should be an
Table 1 Patient characteristics, inflammatory response, type of surgery and outcomes
All patients (n = 305) Non-SSI subgroup (n = 143; 46.9 %) SSI subgroup (n = 162; 53.1 %) P
Age (years) 64.4 ± 14.3 63.5 ± 14.4 65.3 ± 13.8 0.27
Sex (male/ female) 200 (65.6 %)/105 (34.4 %) 86 (60.1 %)/57 (39.9 %) 114 (70.4 %)/48 (29.6 %) 0.07
APACHE II 19.7 ± 7.8 20.5 ± 8.7 18.95 ± 6.6 0.07
SAPS II 36.5 ± 17.1 37.9 ± 19.3 35.1 ± 13.9 0.13
Immunosuppression 36 (11.8 %) 18 (12.6 %) 18 (11.1 %) 0.72
Neutropenia on admission 14 (4.6 %) 7 (4.9 %) 7 (4.3 %) 1.00
HIV 37 (12.1 %) 19 (13.3 %) 18 (11.1 %) 0.60
Type of infection
Secondary peritonitis 140 (45.9 %) 71 (49.6 %) 69 (42.6 %) 0.09
Tertiary peritonitis 165 (54.1 %) 72 (50.4 %) 93 (57.4 %) 0.023
Inflammatory response on admission
Sepsis 27 (8.8 %) 11 (7.7 %) 16 (9.8 %) 0.85
Severe sepsis 32 (10.5 %) 15 (10.5 %) 17 (10.5 %) 1.00
Septic shock 204 (67 %) 89 (62.2 %) 115 (71.1 %) 0.006
Multi-organ failure 42 (13.7 %) 28 (19.5 %) 14 (8.6 %) 0.003
Surgery data
Urgent surgery 276 (90.5 %) 125 (87.4 %) 151 (93.2 %) 0.11
Percutaneous surgery 41 (13.5 %) 17 (11.8 %) 24 (14.8 %) 0.10
Laparoscopic surgery 10 (3.3 %) 4 (2.8 %) 6 (3.7 %) 0.28
Laparotomy surgery 231 (75.7 %) 112 (78.5 %) 119 (73.5 %) 0.12
Combined surgery 23 (7.5 %) 10 (6.9 %) 13 (8 %) 0.14
Number of drainages on ICU admission 2 ± 1.7 1.2 ± 1.7 2.3 ± 1.8 0.01
Outcomes
ARDS 121 (39.6 %) 55 (38.4 %) 66 (40.7 %) 0.85
On mechanical ventilation 279 (91.5 %) 130 (90.9 %) 149 (92 %) 0.83
Arterial lactate on admission (mmol · dL−1) 4.3 ± 3.3 4.1 ± 3.9 5.3 ± 2.5 0.57
RRT 77 (25.2 %) 40 (28 %) 37 (22.8 %) 0.35
Total parenteral Nutrition needs (any time) 251 (82.3 %) 113 (79 %) 138 (85.2 %) 0.17
ICU stay (days) 19.8 ± 24.8 12.9 ± 14.2 22.3 ± 32.9 0.002
Hospital stay (days) 21.7 ± 30 17.6 ± 35.3 25.4 ± 26.5 0.031
In-hospital mortality 115 (38 %) 64 (45.1 %) 110 (31.7 %) 0.018
Data are mean ± standard deviation or percentage
SAPS simplified acute physiology score, APACHE acute physiology and chronic health evaluation, HIV human immunodeficiency virus, ARDS acute respiratory
distress syndrome, RRT renal replacement therapy, ICU intensive care unit
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important component of healthcare quality control
[3, 4]. SSIs may occur following any surgical incision,
even after the use of minimally invasive techniques, so
SSIs need to be reported through systematic monitoring
programmes for nosocomial infection [15]. We showed
that patients suffering from SSI in our cohort had longer
ICU stays. However, we do not think this was simply a
surrogate of higher illness severity in the SSI group be-
cause of the comparable severity scores between groups.
The dominant causative microorganisms and treatment
options have changed over time. Today, most common
pathogens are resistant to common antibiotics [16] with
the need for a high index of suspicion, prompt operative
intervention, appropriate antibiotic treatment and proper
resuscitation [5]. Hypovolemia and hypothermia create
peripheral vasoconstriction that leads to poor tissue perfu-
sion, which facilitates the development of SSI in the pres-
ence of necrotic tissue, foreign bodies, hematomas and
seromas [2]. The microbiology of intra-abdominal infec-
tions also varies depending on the source of infection, prior
use of antibiotics, the site of infection and if it is commu-
nity acquired or nosocomial.
Besides the host and wound factors, physicians should
be aware of the increase in high-virulence species, such
as Staphylococcus aureus and Streptococcus pyogenes. In
addition, Escherichia coli, Bacteroides fragilis and other
gram-negative, anaerobic pathogens are common in large
bowel perforations [16]. Nosocomial intra-abdominal in-
fections often involve microorganisms such as Pseudo-
monas spp., Enterococcus spp. and fungi [5]. In our
population, there was an increased presence of multidrug-
resistant pathogens and fungal SSI rates when compared
with other series [17, 18]. This could be explained by the
higher antibiotic pressure, use of broad-spectrum antibi-
otics, illness severity and prolonged treatment periods. In-
deed, concomitant treatment for peritonitis compounded
matters. We also showed higher reliance on total paren-
teral nutrition (TPN) because enteral nutrition was
poorly tolerated and we opted to initiate it early to avoid
hypoalbuminemia, which is a risk factor for fungal infec-
tion and SSI in critically ill patients [19]. However, we
concede that TPN is a risk factor for all types of fungal
infection in ICU, especially among surgical patients [20].
The increasing trend to reduce hospital stays by imple-
menting innovative surgical techniques (particularly
minimally invasive and endoscopic procedures) makes it
necessary to ensure that accurate measurement and
monitoring of adverse events can take place after dis-
charge. Without doing so, we cannot establish the real
impact of SSI on morbidity and mortality [3, 9, 12]. Con-
trol measures with an emphasis on the education of
healthcare professionals, such as frequent hand washing
and the need to isolate patients with multi-resistant bac-
teria in cluster units, are necessary to reduce SSI rates
Table 2 Microbiology cultures and antibiotic therapy of surgical
site infection
Isolated microorganisms
Escherichia coli 20.4 % (n = 55)
Pseudomonas aeruginosa 19.3 % (n = 52)
Candida albicans 13.7 % (n = 37)
Staphylococcus coagulase negative 12 % (n = 32)
Staphylococcus epidermidis 7.4 % (n = 20)
Enterococcus faecalis 4.4 % (n = 12)
Candida spp. (Other than C. albicans) 3.3 % (n = 9)
Acinetobacter baumanii 2.9 % (n = 8)
Klebsiella spp. 2.6 % (n = 7)
Proteus mirabilis
Methicillin resistant Staphylococcus aureus 2.2 % (n = 6)
Staphylococcus aureus 1.8 % (n = 5)
Enterococcus faecium
Enterobacter cloacae 1.6 % (n = 4)
Clostridium spp.
Enterobacter aerogenes 1.1 % (n = 3)
Other
Antibiotic therapy
Meropenem 28.6 % (n = 203)
Piperacillin-tazobactam 26.1 % (n = 185)
Teicoplanin 12.4 % (n = 89)
Cloxacillin 7.7 % (n = 55)
Fluconazole 7.7 % (n = 54)
Ertapenem 6.7 % (n = 48)
Imipenem-cilastatin 4.8 % (n = 34)
Other 6 % (n = 42)
Fig. 1 Types of surgery based on the anatomical location of the
different identified SSI episodes
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[21]. Although the total elimination of SSI is not pos-
sible, a reduction in the rate of infection to a minimum
should be achievable, even in critically ill patients [4].
Our study presents certain limitations. The most im-
portant is that we used for microbiological sampling a
skin swabs instead of the “gold standard” for culture of
skin, which are tissue biopsy or aspiration sampling of
infected tissue. We could have obtained colonizer micro-
organisms that are not responsible for the infection and
cultures may be misleading organisms in the deep tissue
infection. Thus, our results should be considered cau-
tiously and more studies are needed to confirm them.
Secondly, this was a single-centre observational study
and our results cannot be extrapolated to other less se-
verely ill populations. Among the strengths of this study
are the large sample size, the prospective entry of all
data and the use of postoperative scores, which are not
used in contemporary studies, even though their import-
ance in risk stratification has been emphasised over
recent decades. Furthermore, this investigation was con-
ducted at a large tertiary referral hospital with a high
level of complexity over a four-year period.
Conclusions
In summary, the incidence of SSI was very high in patients
with secondary or tertiary peritonitis requiring ICU admis-
sion. When they prescribe antibiotic therapy, physicians
should consider that microorganisms isolated from pa-
tients with SSI are more likely to include multidrug-
resistant pathogens, including Pseudomonas spp., gram-
positive cocci and fungi, although more studies are needed
to confirm our results due to the inherent limitations of
the microbiological sampling with skin swabs performed in
our research. Despite the presence of an SSI may be associ-
ated with prolonged ICU stays, we did not find any effect
on the in-hospital mortality in our population.
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